129 related articles for article (PubMed ID: 22520669)
1. The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.
Brett T; Arnold-Reed D; Phan C; Cadden F; Walker W; Manea-Walley W; Mora N; Young J; Bulsara M
Br J Gen Pract; 2012 Jan; 62(594):e22-8. PubMed ID: 22520669
[TBL] [Abstract][Full Text] [Related]
2. A telephone-supported cardiovascular lifestyle programme (CLIP) for lipid reduction and weight loss in general practice patients: a randomised controlled pilot trial.
Stuart KL; Wyld B; Bastiaans K; Stocks N; Brinkworth G; Mohr P; Noakes M
Public Health Nutr; 2014 Mar; 17(3):640-7. PubMed ID: 23452940
[TBL] [Abstract][Full Text] [Related]
3. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.
Laatikainen T; Dunbar JA; Chapman A; Kilkkinen A; Vartiainen E; Heistaro S; Philpot B; Absetz P; Bunker S; O'Neil A; Reddy P; Best JD; Janus ED
BMC Public Health; 2007 Sep; 7():249. PubMed ID: 17877832
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial.
Luymes CH; Poortvliet RKE; van Geloven N; de Waal MWM; Drewes YM; Blom JW; Smidt N; Assendelft WJJ; van den Hout WB; de Ruijter W; Numans ME
BMC Med; 2018 Jan; 16(1):5. PubMed ID: 29321031
[TBL] [Abstract][Full Text] [Related]
6. General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.
Jansen J; Bonner C; McKinn S; Irwig L; Glasziou P; Doust J; Teixeira-Pinto A; Hayen A; Turner R; McCaffery K
BMJ Open; 2014 May; 4(5):e004812. PubMed ID: 24833688
[TBL] [Abstract][Full Text] [Related]
7. [GP's intervention in changing lifestyle behavior of adipose patients].
Lazić D; Cikac T; Ozvacić Z; Cop R
Acta Med Croatica; 2007 Feb; 61(1):7-11. PubMed ID: 17593634
[TBL] [Abstract][Full Text] [Related]
8. The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.
Ijzelenberg W; Hellemans IM; van Tulder MW; Heymans MW; Rauwerda JA; van Rossum AC; Seidell JC
BMC Cardiovasc Disord; 2012 Sep; 12():71. PubMed ID: 22962863
[TBL] [Abstract][Full Text] [Related]
9. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
10. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial.
Stewart S; Carrington MJ; Swemmer CH; Anderson C; Kurstjens NP; Amerena J; Brown A; Burrell LM; de Looze FJ; Harris M; Hung J; Krum H; Nelson M; Schlaich M; Stocks NP; Jennings GL;
BMJ; 2012 Nov; 345():e7156. PubMed ID: 23169801
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an intervention to provide brief support and personalized feedback on food shopping to reduce saturated fat intake (PC-SHOP): A randomized controlled trial.
Piernas C; Aveyard P; Lee C; Tsiountsioura M; Noreik M; Astbury NM; Oke J; Madigan C; Jebb SA
PLoS Med; 2020 Nov; 17(11):e1003385. PubMed ID: 33151934
[TBL] [Abstract][Full Text] [Related]
13. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
Lafeber M; Webster R; Visseren FLj; Bots ML; Grobbee DE; Spiering W; Rodgers A;
Eur J Prev Cardiol; 2016 Aug; 23(12):1289-97. PubMed ID: 26743587
[TBL] [Abstract][Full Text] [Related]
14. Scaling-up from an implementation trial to state-wide coverage: results from the preliminary Melbourne Diabetes Prevention Study.
Janus ED; Best JD; Davis-Lameloise N; Philpot B; Hernan A; Bennett CM; O'Reilly S; Carter R; Vartiainen E; Dunbar JA;
Trials; 2012 Aug; 13():152. PubMed ID: 22929458
[TBL] [Abstract][Full Text] [Related]
15. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial.
Byrne JL; Dallosso HM; Rogers S; Gray LJ; Waheed G; Patel P; Gupta P; Doherty Y; Davies MJ; Khunti K
BMC Med; 2020 Jul; 18(1):198. PubMed ID: 32713349
[TBL] [Abstract][Full Text] [Related]
17. A health dialogue intervention reduces cardiovascular risk factor levels: a population based randomised controlled trial in Swedish primary care setting with 1-year follow-up.
Hellstrand M; Simonsson B; Engström S; Nilsson KW; Molarius A
BMC Public Health; 2017 Aug; 17(1):669. PubMed ID: 28830474
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: a nationally representative cross-sectional study.
Banks E; Welsh J; Joshy G; Martin M; Paige E; Korda RJ
BMJ Open; 2020 Dec; 10(12):e038761. PubMed ID: 33371018
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
